{
    "2018-03-16": [
        [
            {
                "time": "2018-03-16",
                "original_text": "安科瑞、中泰化学等12家上市公司2017年度业绩说明会3月16日在全景·路演天下举行",
                "features": {
                    "keywords": [
                        "安科瑞",
                        "中泰化学",
                        "2017年度",
                        "业绩说明会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "[买入评级]乐普医疗(300003)年报点评：业绩符合预期 拟发行可转债收购新东港45%股权",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "年报",
                        "可转债",
                        "新东港",
                        "股权"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "【中信建投证券】每日精华推荐（2018.03.16）",
                "features": {
                    "keywords": [
                        "中信建投证券",
                        "每日精华推荐"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "【医药】理顺管理机制，医改继续前行",
                "features": {
                    "keywords": [
                        "医药",
                        "管理机制",
                        "医改"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "238份年报揭示机构新动向 新进与增持53股",
                "features": {
                    "keywords": [
                        "年报",
                        "机构",
                        "新动向",
                        "新进",
                        "增持"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "社保、险资、QFII和券商四大机构最新A股投资大揭秘！",
                "features": {
                    "keywords": [
                        "社保",
                        "险资",
                        "QFII",
                        "券商",
                        "A股",
                        "投资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "四大机构持仓揭秘:社保青睐化工 券商看重业绩(附股)",
                "features": {
                    "keywords": [
                        "社保",
                        "化工",
                        "券商",
                        "业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "[路演]乐普医疗：今明两年将是公司医疗器械和药品的丰收大年",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "医疗器械",
                        "药品",
                        "丰收大年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "[路演]乐普医疗：几年后国内免疫治疗市场规模将近千亿",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "免疫治疗",
                        "市场规模",
                        "近千亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "医药股“闷声发财”擒消费升级方得奇兵",
                "features": {
                    "keywords": [
                        "医药股",
                        "消费升级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}